文献速递血栓与止血

血小板自身抗体对患者血小板计数有影响

Platelet autoantibodies have an impact on the platelet count in patients.
PubMed 文献 · J Thromb Haemost · 2025-02-25

该回顾性队列研究利用12 335例血小板减少患者的实验室数据,分析GP特异性血小板抗体与血小板计数的关联。结果显示,有抗体者中位血小板计数显著低于无抗体者(54 G/L vs 85 G/L,P < .0001),且针对2个GP的抗体者血小板计数低于针对1个GP者,抗体水平升高与血小板计数降低相关。

要点

  • 有GP特异性血小板抗体者中位血小板计数显著低于无抗体者(54 G/L vs 85 G/L,P < .0001)。
  • 针对2个GP的抗体者血小板计数显著低于针对1个GP者(47 G/L vs 62 G/L,P < .0001)。
  • 抗GPIIb/IIIa和抗GPIb/IX抗体水平升高与血小板计数降低相关(R²=.69,rho -0.84;R²=.57,rho -0.6)。

核心结论

  • 针对GPIIb/IIIa或GPIb/IX的自身抗体存在与较低血小板计数相关。
  • 更多GP被自身抗体靶向及抗体水平升高预测较低血小板计数。
  • 血小板抗体似乎具有临床相关性。

研究设计与样本

  • 大型回顾性队列研究,使用12 335例伴或不伴GP特异性血小板抗体的血小板减少患者的实验室数据。
  • 通过直接GP特异性检测法鉴定针对GPIIb/IIIa和GPIb/IX的血小板抗体。
  • 数据库中鉴定出1469例具有GP特异性血小板抗体且记录完整的成人。

主要发现

  • 与10 866例无抗体成人相比,有抗体患者中位血小板计数显著更低(54 G/L [IQR, 29-89] vs 85 G/L [IQR, 52-123],P < .0001)。
  • 针对2个GP的抗体患者血小板计数显著低于针对1个GP者(47 G/L [IQR, 26-81] vs 62 G/L [IQR, 32-99],P < .0001 for GPIIb/IIIa)。
  • 针对2个GP的抗体患者血小板计数显著低于针对1个GP者(47 G/L [IQR, 26-81] vs 58 G/L [IQR, 32-99],P = .0004 for GPIb/IX)。
  • 抗GPIIb/IIIa抗体水平升高与血小板计数降低相关(R² = .69;rho -0.84)。
  • 抗GPIb/IX抗体水平升高与血小板计数降低相关(R² = .57;rho -0.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is widely accepted that autoantibodies directed against platelet glycoproteins (GPs) are a major pathophysiological mechanism in immune thrombocytopenia, but little clinical data are available demonstrating an association between platelet antibodies and platelet counts. OBJECTIVES: We hypothesized that if platelet antibodies are clinically relevant, the number of targeted GPs and antibody concentration should be associated with the extent of thrombocytopenia. METHODS: Platelet antibodies were identified in a direct GP-specific test that detects antibodies against GPIIb/IIIa and GPIb/IX. Using laboratory data from 12 335 thrombocytopenic patients with and without GP-specific platelet antibodies, we conducted a large retrospective cohort study. RESULTS: We identified 1469 adults with GP-specific platelet antibodies in our database with complete entries. Compared with 10 866 adults without antibodies, patients with antibodies had significantly lower median platelet counts (54 G/L [IQR, 29-89] vs 85 G/L [IQR, 52-123], P < .0001). Patients with antibodies against 2 GPs had significantly lower platelet counts than patients with antibodies against 1 GP (47 G/L [IQR, 26-81] vs 62 G/L [IQR, 32-99], P < .0001 for GPIIb/IIIa and 58 G/L [IQR, 32-99], P = .0004 for GPIb/IX). Increasing antibody levels correlated with decreasing platelet counts for anti-GPIIb/IIIa (R2 = .69; rho -0.84) and anti-GPIb/IX (R2 = .57; rho -0.6). CONCLUSION: The presence of autoantibodies against GPIIb/IIIa or GPIb/IX is associated with lower platelet counts. More GPs targeted by autoantibodies and increasing antibody levels predict lower platelet counts. Platelet antibodies appear to be of clinical relevance.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Sachs UJ, Reich M, Qiu D, et al. Platelet autoantibodies have an impact on the platelet count in patients. J Thromb Haemost. 2025. PMID: 40015377. doi:10.1016/j.jtha.2025.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。